PredictAYA

🌟 Partner spotlight: Inselspital Bern.

The University hospital Bern is one of Switzerland’s leading hospitals. The University Women’s hospital also focuses on research in gonadal toxicity and fertility preservation in cancer disease. In PredictAYA, Bern leads clinical research on ovarian toxicity.

🌟 Partner spotlight: Linköping University @liu.se

LiU advances world-leading, translational research environments. In PredictAYA, LiU contributes to finding predictors of reproductive organ and late toxicity of cancer by working on genetic prediction models and supporting epidemiological studies.

🌟 Partner spotlight: @inserm.fr, @chuangers.bsky.social,
@chulille.bsky.social, @hospicescivilslyon.bsky.social and Centre Leon Berard. The French research and oncology centres contribute to PredictAYA with collection and analysis of data from adolescent and young adult cancer survivors. #HorizonEU

🌟 Partner spotlight: Karolinska University Hospital, @regionstockholm.bsky.social
Karolinska University Hospital ranks among the world's best hospitals. Its clinical program for fertility preservation is the largest in Sweden. In PredictAYA, the hospital provides clinical data and patient inclusion.

🌟 Partner spotlight: @uniheidelberg.bsky.social
The Department of Gynecological Endocrinology and Fertility Disorders at the University of Heidelberg is a leading REI center in Germany. In PredictAYA, it leads communication and stakeholder engagement in Germany for patient recruitment and follow-up.

🌟 Partner spotlight: Civitta Foundation
Civitta is specialised in delivering European projects across diverse sectors. In PredictAYA, the team supports project management and coordination, particularly regarding ethical guidance and data management planning.
#HorizonEU

🌟 Partner spotlight: European Cancer Organisation (ECO), @europeancancer.bsky.social
ECO is a not-for-profit federation of member organisations working in cancer at European level. In PredictAYA, ECO leads stakeholder engagement and policy activities.
#HorizonEU

🌟 Partner spotlight: Université Libre de Bruxelles -
@ulbruxelles.bsky.social
The PredictAYA team at the Research Laboratory on Human Reproduction leads Work Package 6 on reproductive health, sexuality and quality of life after cancer.
#HorizonEU

🌟 Partner spotlight: University of Tartu
The PredictAYA team at the Institute of Clinical Medicine and the Institute of Genomics co-leads Work Package 3 with a focus on developing prediction models for late toxicity or long-term effects of cancer treatment.
#HorizonEU

🌟 Partner spotlight: The University of Florence
In #PredictAYA, Csilla Krausz' team at the Andrology Unit leads research activities to understand and predict late effects of cancer therapies on fertility and testicular function in male adolescent and young adult (AYA) cancer survivors.
#HorizonEU

🌟 Partner spotlight: Netherlands Cancer Institute @nkinl.bsky.social. In #PredictAYA, the research group on personalised oncology in adolescents and young adults leads communication, dissemination and stakeholder engagement and supports studies on late effect of cancer treatment on European cohorts.

🌟 Partner spotlight: Ospedale Policlinico San Martino. In #PredictAYA, the team (@cmassarottimd.bsky.social) co-leads the work on gynecological follow-up after cancer therapies and provides data to analyse late effect of cancer therapies on fertility and reproductive health. #HorizonEU

🌟 Partner spotlight: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. In #PredictAYA, the oncology institute contributes to epidemiological studies of late effects of cancer treatments thanks to the EUROCARE project it leads, as well as research on #fertilitypreservation in AYAs. #HorizonEU

🌟 Partner spotlight: Medical University Innsbruck @i-med.ac.at
The Department of Gynecological Endocrinology & Reproductive Medicine is a leader in #fertilitypreservation & #reproductivehealth. In #PredictAYA, it contributes to clinical data collection across project work packages. #HorizonEU

👋Meet the team in Leeds working on PredictAYA: Adam Glaser, Richard Feltbower - @rgfeltbower.bsky.social, Nicola Hughes, Dan Stark, Helen Picton, Richard Cubbons, and Rebecca Mottram.

🌟 Partner spotlight: @edinburgh-uni.bsky.social‬, Centre for Reproductive Health. In #PredictAYA, the team (@rodtmitchell.bsky.social and Richard Anderson) ‬co-leads work on late effects of #cancertreatment in males and supports research on #reproductivehealth in female #cancer patients. #HorizonEU

🌟 Partner spotlight: @universityofleeds.bsky.social, School of Medicine. In #PredictAYA, the childhood and young adult research group contributes to studying the epidemiology of late effects of cancer treatment in European cohorts, pharmacogenetic modelling and statistical analysis.
#HorizonEU

🌟 Partner spotlight! First up: @ki.se, Laboratory of Translational Fertility Preservation. As coordinator, the team leads key project activities, including epidemiological studies of late effects of #cancer treatment, data collection, statistical analysis, regulatory and ethics guidance.
#HorizonEU

Hello Bluesky!

We are #TRANSCEND-XR, a Horizon Europe project exploring how XR can support young testicular cancer survivors.

Follow us for updates and insights!

#HorizonEurope #DigitalHealth #EUResearch #EUCancerMission #EUResearch

🧬 Why do some #cancer patients face long-term effects from #cancertreatment, such as #infertility, while others don’t? Meet our coordinator Prof. Kenny Rodriguez-Wallberg from @ki.se and read the press release to learn how #PredictAYA will tackle this question.
🔗 news.ki.se/kenny-rodrig...

We're proud to be part of the EU #MissionCancer cluster "Quality of life (AYA)".

🤝 Our consortium is working together to make a difference for AYA cancer patients & survivors, caregivers, healthcare providers, researchers, and policymakers.

Our goals:

🔬 Identify #biomarkers of predict individual susceptibility to treatment‑related organ toxicities.
🎯 Power future #precisionmedicine and #personalisedcare.
🤝 Co‑create with AYA cancer survivors to tailor to #qualityoflife needs.
📘 Shape tomorrow’s care through #clinicalguidelines.

PredictAYA has embarked on a 5-year journey to improve the understanding of late effects of #cancer treatment in adolescents and young adults (AYAs) aged 15-39 years, with a focus on #reproductivehealth.

🚀 #PredictAYA has started its work!

👉Learn more about our project below and follow for updates.

#MissionCancer #CancerSurvivorship #PrecisionMedicine #HorizonEU